These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 7698051)
21. Surgical experience with implantable insulin pumps. Department of Veterans Affairs Implantable Insulin Pump Study Group. Thompson JS; Duckworth WC; Saudek CD; Giobbie-Hurder A Am J Surg; 1998 Dec; 176(6):622-6. PubMed ID: 9926802 [TBL] [Abstract][Full Text] [Related]
22. A method for assessing catheter patency in implanted pumps for long-term intraperitoneal insulin delivery. Scavini M; Hammarberg B; Dosio F; Torri M; Petrella G; Galimberti G; Vai S; Fazio F; Pozza G Artif Organs; 1997 May; 21(5):405-8. PubMed ID: 9129773 [TBL] [Abstract][Full Text] [Related]
23. Lower rate of initial failures and reduced occurrence of adverse events with a new catheter model for continuous subcutaneous insulin infusion: prospective, two-period, observational, multicenter study. Renard E; Guerci B; Leguerrier AM; Boizel R; Diabetes Technol Ther; 2010 Oct; 12(10):769-73. PubMed ID: 20809682 [TBL] [Abstract][Full Text] [Related]
24. Effect of insulin catheter wear-time on subcutaneous adipose tissue blood flow and insulin absorption in humans. Clausen TS; Kaastrup P; Stallknecht B Diabetes Technol Ther; 2009 Sep; 11(9):575-80. PubMed ID: 19764836 [TBL] [Abstract][Full Text] [Related]
25. Risk factors and possible mechanisms of superior vena cava intravenous port malfunction. Wu CY; Hu HC; Ko PJ; Fu JY; Wu CF; Liu YH; Li HJ; Kao TC; Kao KC; Yu SY; Chang CJ; Hsieh HC Ann Surg; 2012 May; 255(5):971-5. PubMed ID: 22504196 [TBL] [Abstract][Full Text] [Related]
26. Strategies for extended lifetime of implantable intraperitoneal insulin catheters. He J; Renard E; Lord P; Cohen D; Gu B; Wang X; Yenduri G; Burgess DJ J Control Release; 2022 Jan; 341():487-497. PubMed ID: 34856228 [TBL] [Abstract][Full Text] [Related]
27. Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with type 1 diabetes. Hoogma RP; Schumicki D Horm Metab Res; 2006 Jun; 38(6):429-33. PubMed ID: 16823727 [TBL] [Abstract][Full Text] [Related]
28. Side effects and indwelling times of subcutaneous catheters for insulin injections: a new device for injecting insulin with a minimum of pain in the treatment of insulin-dependent diabetes mellitus. Hanas R; Ludvigsson J Diabetes Res Clin Pract; 1990; 10(1):73-83. PubMed ID: 2249606 [TBL] [Abstract][Full Text] [Related]
29. Malfunction of continuous subcutaneous insulin infusion systems: a one-year prospective study of 127 patients. Mecklenburg RS; Guinn TS; Sannar CA; Blumenstein BA Diabetes Care; 1986; 9(4):351-5. PubMed ID: 3743310 [TBL] [Abstract][Full Text] [Related]
30. "Catheter-pens"--an alternative to insulin pump treatment? Menzel R; Chlup R; Jutzi E; Hildmann W Exp Clin Endocrinol; 1990 Feb; 95(1):157-69. PubMed ID: 2335181 [TBL] [Abstract][Full Text] [Related]
31. [Implantable insulin pump: surgical implantation under local anesthesia. (Technical note apropos of 35 cases)]. Glock Y; Galinier P; Dalous P; Hanaire-Broutin H; Lacombe S; Lafon F; Tauber JP Ann Chir; 1992; 46(5):445-9. PubMed ID: 1416757 [TBL] [Abstract][Full Text] [Related]
32. [Implantable insulin pumps: evaluation after more than 3 years experience]. Keipes M; Michel G; Pinget M Bull Soc Sci Med Grand Duche Luxemb; 1994; 131(1):17-30. PubMed ID: 8050116 [TBL] [Abstract][Full Text] [Related]
33. Multicentre trial of a programmable implantable insulin pump in type I diabetes. The Point Study II Group. Int J Artif Organs; 1995 Jun; 18(6):322-5. PubMed ID: 8593967 [TBL] [Abstract][Full Text] [Related]
35. Effect of infusion rate and indwelling time on tissue resistance pressure in small-volume subcutaneous infusion like in continuous subcutaneous insulin infusion. Patte C; Pleus S; Wiegel C; Schiltges G; Jendrike N; Haug C; Freckmann G Diabetes Technol Ther; 2013 Apr; 15(4):289-94. PubMed ID: 23427865 [TBL] [Abstract][Full Text] [Related]
36. A preliminary trial of the programmable implantable medication system for insulin delivery. Saudek CD; Selam JL; Pitt HA; Waxman K; Rubio M; Jeandidier N; Turner D; Fischell RE; Charles MA N Engl J Med; 1989 Aug; 321(9):574-9. PubMed ID: 2761602 [TBL] [Abstract][Full Text] [Related]
37. Tunneled internal jugular catheters in adult patients: comparison of outcomes in hemodialysis versus infusion catheters. Peynircioglu B; Ozkan F; Canyigit M; Cil BE; Balkanci F Acta Radiol; 2007 Jul; 48(6):613-9. PubMed ID: 17611867 [TBL] [Abstract][Full Text] [Related]
38. Insulin antibody responses after long-term intraperitoneal insulin administration via implantable programmable insulin delivery systems. Olsen CL; Chan E; Turner DS; Iravani M; Nagy M; Selam JL; Wong ND; Waxman K; Charles MA Diabetes Care; 1994 Mar; 17(3):169-76. PubMed ID: 8174443 [TBL] [Abstract][Full Text] [Related]